LY96
Lymphocyte antigen 96
Also known as: LY96_HUMAN, MD-2
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q9Y6Y9
- Gene
- LY96
- Ensembl
- ENSG00000154589
- Chromosome
- 8
- Canonical length
- 160 aa
- Protein class
- Predicted secreted proteins
- Subcellular location
- Vesicles
- Secretome location
- Secreted to blood
- Quaternary structure
- Homodimer
OverviewNCBI Gene
This gene encodes a protein which associates with toll-like receptor 4 on the cell surface and confers responsiveness to lipopolysaccyaride (LPS), thus providing a link between the receptor and LPS signaling. Studies of the mouse ortholog suggest that this gene may be involved in endotoxin neutralization. Alternative splicing results in multiple transcript variants encoding different isoforms. [provided by RefSeq, Sep 2010]
Canonical amino-acid sequenceUniProt
160 residues, UniProt reviewed canonical sequence.
>Q9Y6Y9|LY96
1 MLPFLFFSTL FSSIFTEAQK QYWVCNSSDA SISYTYCDKM QYPISINVNP CIELKRSKGL
61 LHIFYIPRRD LKQLYFNLYI TVNTMNLPKR KEVICRGSDD DYSFCRALKG ETVNTTISFS
121 FKGIKFSKGK YKCVVEAISG SPEEMLFCLE FVILHQPNSNLocalizationUniProt · AlphaFold · HPA
Whether an antibody against LY96 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Secreted
- Secreted
- Yes
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.34
- Highest tissue expression
- 61 nTPM
Expression across tissuesHPA
Tissue
- spleen: 61 nTPM
- lymph node: 44 nTPM
- placenta: 42 nTPM
- appendix: 40 nTPM
- tonsil: 37 nTPM
- gallbladder: 33 nTPM
Single-cell type
- kupffer cells: 1,098 nCPM
- hofbauer cells: 1,026 nCPM
- neutrophils: 598 nCPM
- macrophages: 187 nCPM
- plasma cells: 179 nCPM
- monocytes: 157 nCPM
Immune cell
- neutrophil: 632 nTPM
- classical monocyte: 91 nTPM
- intermediate monocyte: 85 nTPM
- non-classical monocyte: 72 nTPM
- myeloid DC: 46 nTPM
- plasmacytoid DC: 38 nTPM
Brain region
- white matter: 12 nTPM
- medulla oblongata: 11 nTPM
- spinal cord: 7.8 nTPM
- pons: 7.6 nTPM
- hypothalamus: 7 nTPM
- thalamus: 6 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 1.49
- gnomAD pLI
- 0
- gnomAD missense Z
- 0.15
- DepMap mean gene effect
- 0
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 6% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- cell surface receptor signaling pathway
- cellular defense response
- cellular response to lipopolysaccharide
- detection of lipopolysaccharide
- inflammatory response
- innate immune response
- positive regulation of lipopolysaccharide-mediated signaling pathway
- positive regulation of tumor necrosis factor production
- response to lipopolysaccharide
- toll-like receptor 4 signaling pathway
- toll-like receptor signaling pathway
Molecular functions
- coreceptor activity
- lipopolysaccharide binding
- lipopolysaccharide immune receptor activity
- Toll-like receptor 4 binding
Cellular components
Protein domainsUniProt · Pfam · InterPro
- MD-2-related lipid-recognition domain
- Immunoglobulin E-set
- ML domain
- Lymphocyte antigen 96
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of LY96 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads LY96 as an antibody target. Whether an autoantibody or antibody against LY96 could matter depends on whether native LY96 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
LY96 is annotated as secreted, so native LY96 circulates and is directly accessible to antibodies. Secreted and cell-surface proteins are the autoantibody targets most likely to act like drugs, blocking or depleting the native protein.
Annotation status
The present source text does not explicitly label LY96 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...